Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Bristol Myers Squibb discloses new FPR2 agonists

Jan. 11, 2021

Novartis presents new NPR1-targeting antibodies

Jan. 5, 2021

Novel urotensin II receptor antagonists show efficacy in a mouse pressor response model

Jan. 4, 2021

BIAL-Portela & Ca. discovers dopamine beta-monooxygenase inhibitors

Dec. 30, 2020

Novel lipid conjugates of APJ agonist peptides show prolonged half-life for once-daily dosing

Dec. 30, 2020

Discovery and preclinical evaluation of a new sGC stimulator for hypertension treatment

Dec. 18, 2020

Merck & Co. patents NPR1 agonists

Dec. 16, 2020

Mesoblast reports topline phase III data on Revascor in advanced chronic heart failure

Dec. 15, 2020

Regenerative approach shows promise in pediatric heart disease

Dec. 14, 2020

Cytokinetics advances phase II trial of CK-3773274 for symptomatic obstructive HCM

Dec. 10, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...